Free Trial

Linde (LIN) Financials

Linde logo
$475.63 +2.40 (+0.51%)
Closing price 08/13/2025 04:00 PM Eastern
Extended Trading
$475.47 -0.16 (-0.03%)
As of 06:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Linde

Annual Income Statements for Linde

This table shows Linde's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
1,500 1,247 4,381 2,285 2,501 3,826 4,147 6,199 6,565
Consolidated Net Income / (Loss)
1,538 1,308 4,405 2,381 2,626 3,961 4,281 6,341 6,737
Net Income / (Loss) Continuing Operations
1,538 1,308 4,288 2,272 2,622 3,956 4,281 6,341 6,737
Total Pre-Tax Income
2,048 2,287 5,049 2,927 3,384 5,099 5,543 7,988 8,569
Total Operating Income
2,247 2,444 5,247 2,933 3,322 4,984 5,369 8,024 8,635
Total Gross Profit
4,679 4,976 5,816 11,584 11,860 13,250 13,914 15,362 15,862
Total Revenue
10,534 11,358 14,836 28,228 27,243 30,793 33,364 32,854 33,005
Operating Revenue
10,534 11,358 14,836 28,228 27,243 30,793 33,364 32,854 33,005
Total Cost of Revenue
5,855 6,382 9,020 16,644 15,383 17,543 19,450 17,492 17,143
Operating Cost of Revenue
5,855 6,382 9,020 16,644 15,383 17,543 19,450 17,492 17,143
Total Operating Expenses
2,432 2,532 569 8,651 8,538 8,266 8,545 7,338 7,227
Selling, General & Admin Expense
1,145 1,207 1,629 3,457 3,193 3,189 3,107 3,295 3,337
Research & Development Expense
92 93 113 184 152 143 143 146 150
Depreciation Expense
1,122 1,184 1,830 4,675 4,626 4,635 4,204 3,816 3,780
Other Operating Expenses / (Income)
-23 -4.00 -3,312 -232 61 26 62 41 -185
Restructuring Charge
- - - - 506 273 1,029 40 145
Total Other Income / (Expense), net
-199 -157 -198 -6.00 62 115 174 -36 -66
Interest Expense
190 161 202 38 115 77 63 200 256
Other Income / (Expense), net
-9.00 4.00 4.00 32 177 192 237 164 190
Income Tax Expense
551 1,026 817 769 847 1,262 1,434 1,814 2,002
Other Gains / (Losses), net
41 47 56 114 85 119 172 167 170
Net Income / (Loss) Attributable to Noncontrolling Interest
38 61 24 96 125 135 134 142 172
Weighted Average Basic Shares Outstanding
285.68M 286.26M 330.40M 541.09M 526.74M 516.90M 499.74M 488.19M 478.77M
Diluted Earnings per Share
$5.21 $4.32 $13.11 $4.19 $4.71 $7.33 $8.23 $12.59 $13.62
Weighted Average Diluted Shares Outstanding
287.76M 289.11M 334.13M 545.17M 531.16M 521.88M 504.04M 492.29M 482.09M
Weighted Average Basic & Diluted Shares Outstanding
- 286M 330.40M 532.96M 522.84M 507.74M 492.16M 481.58M 472.91M
Cash Dividends to Common per Share
$3.00 $3.15 $3.30 $3.50 $3.85 $4.24 $4.68 $5.10 $5.56

Quarterly Income Statements for Linde

This table shows Linde's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
1,328 1,516 1,575 1,565 1,543 1,627 1,663 1,550 1,725 1,673 1,766
Consolidated Net Income / (Loss)
1,361 1,552 1,612 1,601 1,576 1,665 1,700 1,603 1,769 1,707 1,806
Net Income / (Loss) Continuing Operations
1,361 1,552 1,612 1,601 1,576 1,665 1,700 1,603 1,769 1,707 1,806
Total Pre-Tax Income
1,714 1,941 2,004 2,047 1,996 2,080 2,163 2,063 2,263 2,180 2,346
Total Operating Income
1,687 1,933 2,011 2,052 2,028 2,095 2,184 2,086 2,270 2,184 2,354
Total Gross Profit
3,472 3,762 3,888 3,841 3,871 3,884 4,016 4,000 3,962 3,955 4,189
Total Revenue
7,899 8,193 8,204 8,155 8,302 8,100 8,267 8,356 8,282 8,112 8,495
Operating Revenue
7,899 8,193 8,204 8,155 8,302 8,100 8,267 8,356 8,282 8,112 8,495
Total Cost of Revenue
4,427 4,431 4,316 4,314 4,431 4,216 4,251 4,356 4,320 4,157 4,306
Operating Cost of Revenue
4,427 4,431 4,316 4,314 4,431 4,216 4,251 4,356 4,320 4,157 4,306
Total Operating Expenses
1,785 1,829 1,877 1,789 1,843 1,789 1,832 1,914 1,692 1,771 1,835
Selling, General & Admin Expense
764 822 833 808 832 860 840 823 814 786 870
Research & Development Expense
36 36 35 36 39 38 36 37 39 38 38
Depreciation Expense
956 948 960 959 949 949 958 960 913 910 942
Other Operating Expenses / (Income)
4.00 5.00 27 -16 25 -58 -2.00 -51 -74 -18 -15
Restructuring Charge
25 18 22 2.00 -2.00 0.00 0.00 145 - 55 0.00
Total Other Income / (Expense), net
27 8.00 -7.00 -5.00 -32 -15 -21 -23 -7.00 -4.00 -8.00
Interest Expense
31 37 52 40 71 65 70 68 53 60 67
Other Income / (Expense), net
58 45 45 35 39 50 49 45 46 56 59
Income Tax Expense
388 430 438 487 459 463 508 498 533 511 573
Other Gains / (Losses), net
35 41 46 41 39 48 45 38 39 38 33
Net Income / (Loss) Attributable to Noncontrolling Interest
33 36 37 36 33 38 37 53 44 34 40
Weighted Average Basic Shares Outstanding
499.74M 491.82M 489.62M 487.12M 488.19M 481.95M 479.97M 477.66M 478.77M 473.30M 470.87M
Diluted Earnings per Share
$2.65 $3.06 $3.19 $3.19 $3.15 $3.35 $3.44 $3.22 $3.61 $3.51 $3.73
Weighted Average Diluted Shares Outstanding
504.04M 495.68M 493.55M 491.08M 492.29M 485.59M 483.18M 480.90M 482.09M 476.26M 473.57M
Weighted Average Basic & Diluted Shares Outstanding
492.16M 490.25M 487.95M 484.89M 481.58M 480.68M 477.50M 476.16M 472.91M 471.29M 468.91M
Cash Dividends to Common per Share
- $1.28 $1.28 $1.28 - $1.39 $1.39 $1.39 - - $1.50

Annual Cash Flow Statements for Linde

This table details how cash moves in and out of Linde's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
723 -51 4,073 -1,752 1,054 -931 2,613 -772 186
Net Cash From Operating Activities
2,789 2,919 3,702 6,010 7,429 9,725 8,864 9,305 9,423
Net Cash From Continuing Operating Activities
2,789 3,041 3,654 6,119 7,429 9,725 8,864 9,305 9,423
Net Income / (Loss) Continuing Operations
1,538 1,308 4,288 2,272 2,622 3,956 4,281 6,341 6,737
Consolidated Net Income / (Loss)
1,538 1,186 4,396 2,374 2,622 3,826 4,281 6,341 6,737
Depreciation Expense
1,122 1,184 1,830 4,675 4,626 4,635 4,204 3,816 3,780
Non-Cash Adjustments To Reconcile Net Income
68 128 -2,646 -289 174 1,649 577 -18 -23
Changes in Operating Assets and Liabilities, net
61 421 -186 -551 7.00 -380 -198 -834 -1,071
Net Cash From Investing Activities
-1,407 -1,314 5,340 1,129 -2,986 -3,007 -3,088 -4,670 -4,644
Net Cash From Continuing Investing Activities
-1,407 -1,314 5,363 1,189 -2,986 -3,007 -3,088 -4,670 -4,644
Purchase of Property, Plant & Equipment
-1,465 -1,311 -1,883 -3,682 -3,400 -3,086 -3,173 -3,787 -4,497
Acquisitions
- -33 -25 -225 -68 -88 -110 -953 -317
Divestitures
58 30 5,908 5,096 482 167 195 70 170
Net Cash From Financing Activities
-659 -1,656 -4,996 -8,992 -3,345 -7,588 -3,089 -5,400 -4,359
Net Cash From Continuing Financing Activities
-659 -1,656 -4,998 -8,997 -3,345 -7,588 -3,089 -5,400 -4,359
Repayment of Debt
-841 -874 -3,526 -4,843 -1,703 -1,791 -1,873 -1,735 -1,725
Repurchase of Common Equity
-228 -12 -599 -2,658 -2,457 -4,612 -5,168 -3,958 -4,482
Payment of Dividends
-856 -901 -1,166 -1,891 -2,028 -2,189 -2,344 -2,482 -2,655
Issuance of Debt
1,127 11 216 323 2,796 954 6,260 2,742 4,472
Issuance of Common Equity
139 120 77 72 47 50 36 33 31
Other Net Changes in Cash
0.00 0.00 27 -77 - -61 -74 -7.00 -234
Cash Interest Paid
189 184 214 275 322 233 170 451 443
Cash Income Taxes Paid
585 565 757 1,357 1,066 1,710 1,735 1,955 2,216

Quarterly Cash Flow Statements for Linde

This table details how cash moves in and out of Linde's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
1,680 -474 -1,605 537 770 184 3,202 -2,917 -283 444 -508
Net Cash From Operating Activities
2,095 1,908 2,150 2,520 2,727 1,954 1,929 2,731 2,809 2,161 2,211
Net Cash From Continuing Operating Activities
2,196 1,904 2,215 2,350 2,836 1,989 5,222 -687 2,937 2,152 2,233
Net Income / (Loss) Continuing Operations
1,462 1,552 1,612 1,492 1,685 1,665 5,028 -1,815 1,897 1,707 1,806
Consolidated Net Income / (Loss)
1,462 1,516 1,648 1,492 1,685 1,665 5,028 -1,815 1,897 1,707 1,806
Depreciation Expense
956 948 960 959 949 949 958 960 913 910 942
Non-Cash Adjustments To Reconcile Net Income
-410 -61 66 6.00 -29 -17 -169 48 115 60 14
Changes in Operating Assets and Liabilities, net
188 -499 -459 -107 231 -608 -595 120 12 -525 -529
Net Cash From Investing Activities
-881 -1,634 -864 -946 -1,226 -1,041 -1,270 -957 -1,376 -1,369 -1,457
Net Cash From Continuing Investing Activities
-881 -1,634 -864 -946 -1,226 -1,041 -1,270 -957 -1,376 -1,369 -1,457
Purchase of Property, Plant & Equipment
-936 -829 -859 -948 -1,151 -1,048 -1,133 -1,066 -1,250 -1,270 -1,257
Acquisitions
- -808 -26 -8.00 -111 0.00 -152 -23 -142 -112 -158
Divestitures
55 3.00 21 10 36 7.00 15 132 16 13 11
Net Cash From Financing Activities
390 -764 -2,892 -964 -780 -668 -808 -1,273 -1,610 -388 -1,366
Net Cash From Continuing Financing Activities
390 -764 -2,892 -964 -780 -668 -808 -1,273 -1,610 -388 -1,366
Repayment of Debt
-2,315 -554 -1,109 -314 242 -799 -1,080 41 744 -1,085 -534
Repurchase of Common Equity
-690 -859 -908 -1,158 -1,033 -1,041 -1,440 -667 -1,334 -1,111 -1,111
Payment of Dividends
-586 -623 -623 -620 -616 -669 -665 -662 -659 -708 -704
Issuance of Debt
3,969 1,259 -260 1,124 619 1,825 2,372 8.00 -364 2,505 979
Issuance of Common Equity
12 13 8.00 4.00 8.00 16 5.00 7.00 3.00 11 4.00
Other Net Changes in Cash
- 16 1.00 - - -61 - - - 40 104

Annual Balance Sheets for Linde

This table presents Linde's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
20,436 93,386 86,612 88,229 81,605 79,658 80,811 80,147
Total Current Assets
3,285 17,272 10,352 10,924 10,159 13,047 12,620 12,945
Cash & Equivalents
617 4,466 2,700 3,754 2,823 5,436 4,664 4,850
Accounts Receivable
1,710 4,297 4,322 4,167 4,499 4,559 4,718 4,622
Inventories, net
614 1,651 1,697 1,729 1,733 1,978 2,115 1,946
Other Current Assets
344 1,360 1,633 1,274 1,104 1,074 1,123 1,527
Plant, Property, & Equipment, net
11,825 29,717 0.00 0.00 26,003 23,548 24,552 24,775
Total Noncurrent Assets
5,326 46,397 76,260 77,305 45,443 43,063 43,639 42,427
Goodwill
3,233 26,874 27,019 28,201 27,038 25,817 26,751 25,937
Intangible Assets
785 16,223 16,137 16,184 13,802 12,420 12,399 11,330
Other Noncurrent Operating Assets
581 1,462 31,077 30,859 1,984 2,476 2,299 5,160
Total Liabilities & Shareholders' Equity
20,436 93,386 86,612 88,229 81,605 79,658 80,811 80,147
Total Liabilities
13,914 36,290 34,977 38,647 36,164 38,271 39,716 40,659
Total Current Liabilities
3,307 12,956 12,160 13,740 13,643 16,479 15,717 14,544
Short-Term Debt
1,217 3,008 3,263 4,002 2,872 5,716 5,976 6,280
Accounts Payable
922 3,219 3,266 3,095 3,503 2,995 3,020 2,507
Current Deferred Revenue
0.00 1,546 1,758 1,769 - 3,073 1,901 1,194
Other Current Liabilities
926 3,758 3,503 4,332 6,839 4,082 4,156 4,563
Total Noncurrent Liabilities
10,607 23,334 22,817 24,907 22,521 21,792 23,999 26,115
Long-Term Debt
7,783 12,288 10,693 12,152 11,335 12,198 13,397 15,343
Other Noncurrent Operating Liabilities
1,588 3,435 4,888 5,519 4,188 2,795 3,804 10,772
Redeemable Noncontrolling Interest
11 16 113 13 13 13 13 13
Total Equity & Noncontrolling Interests
6,511 57,080 51,522 49,569 45,428 41,374 41,082 39,475
Total Preferred & Common Equity
6,018 51,596 49,074 47,317 44,035 40,028 39,720 38,092
Total Common Equity
6,018 51,596 49,074 47,317 44,035 40,028 39,720 38,092
Common Stock
4,088 40,152 40,202 40,203 40,181 40,006 39,813 39,604
Retained Earnings
13,224 16,529 16,842 17,178 18,710 20,541 8,845 12,634
Treasury Stock
-7,196 -629 -3,156 -5,374 -9,808 -14,737 -3,133 -7,252
Accumulated Other Comprehensive Income / (Loss)
-4,098 -4,456 -4,814 -4,690 -5,048 -5,782 -5,805 -6,894
Noncontrolling Interest
493 5,484 2,448 2,252 1,393 1,346 1,362 1,383

Quarterly Balance Sheets for Linde

This table presents Linde's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets
79,658 80,308 78,718 77,827 80,811 80,347 80,215 82,546 80,147 82,704 86,078
Total Current Assets
13,047 12,904 11,411 11,737 12,620 13,102 12,843 13,460 12,945 13,597 13,627
Cash & Equivalents
5,436 4,962 3,357 3,894 4,664 4,848 4,626 5,187 4,850 5,294 4,786
Accounts Receivable
4,559 4,753 4,799 4,692 4,718 5,009 5,001 4,871 4,622 4,950 5,230
Inventories, net
1,978 2,054 2,079 2,078 2,115 2,100 2,094 2,087 1,946 1,984 2,122
Other Current Assets
1,074 1,135 1,176 1,073 1,123 1,145 1,122 1,315 1,527 1,369 1,489
Plant, Property, & Equipment, net
23,548 23,796 23,808 23,624 24,552 24,418 24,575 25,124 24,775 25,710 26,928
Total Noncurrent Assets
43,063 43,608 43,499 42,466 43,639 42,827 42,797 43,962 42,427 43,397 45,523
Goodwill
25,817 26,418 26,456 25,955 26,751 26,289 26,365 27,108 25,937 26,507 27,812
Intangible Assets
12,420 12,638 12,510 12,092 12,399 12,001 11,851 12,113 11,330 11,561 12,082
Other Noncurrent Operating Assets
2,476 4,552 4,533 4,419 2,299 4,537 4,581 4,741 3,030 5,329 5,629
Total Liabilities & Shareholders' Equity
79,658 80,308 78,718 77,827 80,811 80,347 80,215 82,546 80,147 82,704 86,078
Total Liabilities
38,271 38,972 37,470 37,589 39,716 40,118 40,664 41,943 40,659 43,241 46,092
Total Current Liabilities
16,479 17,785 14,552 14,162 15,717 14,389 13,504 14,049 14,544 14,485 14,714
Short-Term Debt
5,716 7,033 3,962 4,771 5,976 5,092 4,587 4,787 6,280 6,289 6,219
Accounts Payable
2,995 2,941 2,977 2,750 3,020 2,885 2,859 2,845 2,507 2,446 2,593
Current Deferred Revenue
3,073 - - - 1,901 1,827 1,767 1,727 1,194 1,196 1,261
Other Current Liabilities
4,082 7,811 7,613 6,641 4,156 4,585 4,291 4,690 3,926 4,554 4,641
Total Noncurrent Liabilities
21,792 21,187 22,918 23,427 23,999 25,729 27,160 27,894 26,115 28,756 31,378
Long-Term Debt
12,198 11,744 13,528 13,232 13,397 15,227 16,931 17,475 15,343 17,608 19,701
Other Noncurrent Operating Liabilities
2,795 9,443 9,390 10,195 3,804 10,502 10,229 10,419 4,015 11,148 11,677
Redeemable Noncontrolling Interest
13 13 13 13 13 13 13 13 13 13 13
Total Equity & Noncontrolling Interests
41,374 41,323 41,235 40,225 41,082 40,216 39,538 40,590 39,475 39,450 39,973
Total Preferred & Common Equity
40,028 39,970 39,911 38,898 39,720 38,829 38,179 39,173 38,092 38,032 38,515
Total Common Equity
40,028 39,970 39,911 38,898 39,720 38,829 38,179 39,173 38,092 38,032 38,515
Common Stock
40,006 39,859 39,797 39,803 39,813 39,571 39,561 39,574 39,604 39,409 39,412
Retained Earnings
20,541 6,092 7,024 7,940 8,845 9,708 10,721 11,585 12,634 13,545 14,595
Treasury Stock
-14,737 -171 -1,011 -2,169 -3,133 -3,922 -5,309 -5,927 -7,252 -8,154 -9,242
Accumulated Other Comprehensive Income / (Loss)
-5,782 -5,810 -5,899 -6,676 -5,805 -6,528 -6,794 -6,059 -6,894 -6,768 -6,250
Noncontrolling Interest
1,346 1,353 1,324 1,327 1,362 1,387 1,359 1,417 1,383 1,418 1,458

Annual Metrics And Ratios for Linde

This table displays calculated financial ratios and metrics derived from Linde's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 7.82% 30.62% 90.27% -3.49% 13.03% 8.35% -1.53% 0.46%
EBITDA Growth
0.00% 8.10% 105.09% 2.73% 6.18% 20.75% -0.01% 22.36% 5.01%
EBIT Growth
0.00% 9.38% 114.50% -43.53% 18.01% 47.93% 8.31% 46.06% 7.78%
NOPAT Growth
0.00% -17.95% 226.36% -50.83% 15.17% 50.59% 6.12% 55.82% 6.70%
Net Income Growth
0.00% -14.95% 236.77% -45.95% 10.29% 50.84% 8.08% 48.12% 6.25%
EPS Growth
0.00% -17.08% 203.47% -68.04% 12.41% 55.63% 12.28% 52.98% 8.18%
Operating Cash Flow Growth
0.00% 4.66% 26.82% 62.34% 23.61% 30.91% -8.85% 4.98% 1.27%
Free Cash Flow Firm Growth
0.00% 0.00% -233.44% 106.21% 29.25% 175.68% -29.52% -38.50% 48.69%
Invested Capital Growth
0.00% 0.00% 332.77% -0.81% -1.55% -9.54% -4.96% 4.07% 0.96%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 4.75% 0.71% 3.45% -1.18% 1.24% -0.06%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -25.92% 5.52% 2.66% 1.87% 2.69% 1.72%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -46.43% 12.73% 6.39% 6.84% 4.09% 2.90%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -52.34% 12.74% 6.35% 8.21% 4.32% 2.70%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -50.36% 11.27% 6.79% 7.67% 3.51% 2.95%
EPS Q/Q Growth
0.00% 0.00% 0.00% -63.69% 12.14% 7.95% 8.72% 4.14% 3.50%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 12.61% 4.38% 8.95% -11.38% 7.29% 0.88%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 7.94% 36.07% -38.92% 93.60% 95.98%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -2.09% -2.08% -6.16% 1.97% -1.35% -6.15%
Profitability Metrics
- - - - - - - - -
Gross Margin
44.42% 43.81% 39.20% 41.04% 43.53% 43.03% 41.70% 46.76% 48.06%
EBITDA Margin
31.90% 31.98% 50.21% 27.11% 29.82% 31.86% 29.40% 36.54% 38.19%
Operating Margin
21.33% 21.52% 35.37% 10.39% 12.19% 16.19% 16.09% 24.42% 26.16%
EBIT Margin
21.25% 21.55% 35.39% 10.50% 12.84% 16.81% 16.80% 24.92% 26.74%
Profit (Net Income) Margin
14.60% 11.52% 29.69% 8.43% 9.64% 12.86% 12.83% 19.30% 20.41%
Tax Burden Percent
75.10% 57.19% 87.25% 81.35% 77.60% 77.68% 77.23% 79.38% 78.62%
Interest Burden Percent
91.51% 93.42% 96.15% 98.72% 96.71% 98.51% 98.88% 97.56% 97.10%
Effective Tax Rate
26.90% 44.86% 16.18% 26.27% 25.03% 24.75% 25.87% 22.71% 23.36%
Return on Invested Capital (ROIC)
0.00% 19.01% 11.64% 3.54% 4.12% 6.57% 7.53% 11.80% 12.28%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 17.98% 11.76% 6.78% 5.51% 8.78% 10.72% 13.03% 13.16%
Return on Net Nonoperating Assets (RNNOA)
0.00% 21.10% 2.20% 0.84% 1.07% 1.76% 2.33% 3.58% 4.44%
Return on Equity (ROE)
0.00% 40.11% 13.85% 4.38% 5.19% 8.34% 9.86% 15.38% 16.72%
Cash Return on Invested Capital (CROIC)
0.00% -180.99% -113.28% 4.35% 5.69% 16.59% 12.62% 7.81% 11.32%
Operating Return on Assets (OROA)
0.00% 11.98% 9.23% 3.29% 4.00% 6.10% 6.95% 10.21% 10.97%
Return on Assets (ROA)
0.00% 6.40% 7.74% 2.65% 3.00% 4.66% 5.31% 7.90% 8.37%
Return on Common Equity (ROCE)
0.00% 37.01% 12.54% 4.05% 4.94% 8.01% 9.55% 14.87% 16.15%
Return on Equity Simple (ROE_SIMPLE)
0.00% 21.73% 8.54% 4.85% 5.55% 9.00% 10.70% 15.96% 17.69%
Net Operating Profit after Tax (NOPAT)
1,642 1,348 4,398 2,162 2,491 3,750 3,980 6,202 6,618
NOPAT Margin
15.59% 11.86% 29.64% 7.66% 9.14% 12.18% 11.93% 18.88% 20.05%
Net Nonoperating Expense Percent (NNEP)
0.00% 1.03% -0.12% -3.24% -1.38% -2.20% -3.19% -1.23% -0.88%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 6.71% 10.26% 10.83%
Cost of Revenue to Revenue
55.58% 56.19% 60.80% 58.96% 56.47% 56.97% 58.30% 53.24% 51.94%
SG&A Expenses to Revenue
10.87% 10.63% 10.98% 12.25% 11.72% 10.36% 9.31% 10.03% 10.11%
R&D to Revenue
0.87% 0.82% 0.76% 0.65% 0.56% 0.46% 0.43% 0.44% 0.45%
Operating Expenses to Revenue
23.09% 22.29% 3.84% 30.65% 31.34% 26.84% 25.61% 22.34% 21.90%
Earnings before Interest and Taxes (EBIT)
2,238 2,448 5,251 2,965 3,499 5,176 5,606 8,188 8,825
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,360 3,632 7,449 7,652 8,125 9,811 9,810 12,004 12,605
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.54 2.19 2.80 3.92 3.93 5.03 5.41
Price to Tangible Book Value (P/TBV)
0.00 0.00 9.35 18.19 45.16 53.99 87.74 350.35 249.76
Price to Revenue (P/Rev)
0.00 0.00 5.35 3.81 4.86 5.60 4.71 6.08 6.24
Price to Earnings (P/E)
0.00 0.00 18.13 47.11 52.94 45.08 37.89 32.21 31.39
Dividend Yield
2.03% 0.00% 1.14% 2.16% 1.53% 1.26% 1.47% 1.26% 1.33%
Earnings Yield
0.00% 35,488.52% 5.52% 2.12% 1.89% 2.22% 2.64% 3.10% 3.19%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.58 1.53 1.96 2.42 3.37 3.27 3.98 4.10
Enterprise Value to Revenue (EV/Rev)
0.00 0.72 6.33 4.23 5.32 5.93 5.05 6.50 6.73
Enterprise Value to EBITDA (EV/EBITDA)
0.00 2.25 12.61 15.61 17.85 18.62 17.19 17.79 17.62
Enterprise Value to EBIT (EV/EBIT)
0.00 3.33 17.89 40.29 41.44 35.29 30.08 26.09 25.17
Enterprise Value to NOPAT (EV/NOPAT)
0.00 6.06 21.36 55.24 58.23 48.70 42.37 34.44 33.56
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 2.80 25.37 19.87 19.52 18.78 19.02 22.95 23.57
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 44.97 42.23 19.30 25.28 52.06 36.41
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 1.38 0.27 0.27 0.33 0.31 0.43 0.47 0.55
Long-Term Debt to Equity
0.00 1.19 0.22 0.21 0.25 0.25 0.29 0.33 0.39
Financial Leverage
0.00 1.17 0.19 0.12 0.19 0.20 0.22 0.27 0.34
Leverage Ratio
0.00 3.13 1.79 1.66 1.73 1.79 1.86 1.95 2.00
Compound Leverage Factor
0.00 2.93 1.72 1.63 1.67 1.76 1.84 1.90 1.94
Debt to Total Capital
0.00% 57.98% 21.13% 21.28% 24.57% 23.82% 30.21% 32.04% 35.38%
Short-Term Debt to Total Capital
0.00% 7.84% 4.16% 4.97% 6.09% 4.81% 9.64% 9.88% 10.28%
Long-Term Debt to Total Capital
0.00% 50.14% 16.97% 16.30% 18.49% 19.00% 20.57% 22.16% 25.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 3.25% 7.60% 3.90% 3.45% 2.36% 2.29% 2.27% 2.28%
Common Equity to Total Capital
0.00% 38.77% 71.27% 74.82% 71.98% 73.82% 67.50% 65.69% 62.33%
Debt to EBITDA
0.00 2.48 2.05 1.82 1.99 1.45 1.83 1.61 1.72
Net Debt to EBITDA
0.00 2.11 1.21 1.21 1.27 0.89 1.03 1.04 1.16
Long-Term Debt to EBITDA
0.00 2.14 1.65 1.40 1.50 1.16 1.24 1.12 1.22
Debt to NOPAT
0.00 6.68 3.48 6.45 6.49 3.79 4.50 3.12 3.27
Net Debt to NOPAT
0.00 5.68 2.04 4.27 4.15 2.34 2.54 2.02 2.21
Long-Term Debt to NOPAT
0.00 5.78 2.79 4.94 4.88 3.02 3.06 2.16 2.32
Altman Z-Score
0.00 1.86 1.96 2.53 2.73 3.72 3.42 3.87 4.01
Noncontrolling Interest Sharing Ratio
0.00% 7.73% 9.44% 7.41% 4.77% 3.86% 3.18% 3.31% 3.44%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 0.99 1.33 0.85 0.80 0.74 0.79 0.80 0.89
Quick Ratio
0.00 0.70 0.68 0.58 0.58 0.54 0.61 0.60 0.65
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -12,830 -42,782 2,656 3,434 9,465 6,671 4,103 6,101
Operating Cash Flow to CapEx
190.38% 222.65% 196.60% 163.23% 218.50% 315.13% 279.36% 245.71% 209.54%
Free Cash Flow to Firm to Interest Expense
0.00 -79.69 -211.79 69.91 29.86 122.93 105.89 20.51 23.83
Operating Cash Flow to Interest Expense
14.68 18.13 18.33 158.16 64.60 126.30 140.70 46.53 36.81
Operating Cash Flow Less CapEx to Interest Expense
6.97 9.99 9.01 61.26 35.03 86.22 90.33 27.59 19.24
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.56 0.26 0.31 0.31 0.36 0.41 0.41 0.41
Accounts Receivable Turnover
0.00 6.64 4.94 6.55 6.42 7.11 7.37 7.08 7.07
Inventory Turnover
0.00 10.39 7.96 9.94 8.98 10.13 10.48 8.55 8.44
Fixed Asset Turnover
0.00 0.96 0.71 0.00 0.00 0.00 1.35 1.37 1.34
Accounts Payable Turnover
0.00 6.92 4.36 5.13 4.84 5.32 5.99 5.82 6.20
Days Sales Outstanding (DSO)
0.00 54.95 73.89 55.72 56.87 51.36 49.55 51.53 51.65
Days Inventory Outstanding (DIO)
0.00 35.12 45.83 36.71 40.65 36.02 34.82 42.70 43.23
Days Payable Outstanding (DPO)
0.00 52.73 83.78 71.11 75.47 68.64 60.97 62.76 58.84
Cash Conversion Cycle (CCC)
0.00 37.34 35.94 21.33 22.05 18.74 23.40 31.48 36.04
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 14,178 61,358 60,864 59,921 54,206 51,515 53,614 54,131
Invested Capital Turnover
0.00 1.60 0.39 0.46 0.45 0.54 0.63 0.63 0.61
Increase / (Decrease) in Invested Capital
0.00 14,178 47,180 -494 -943 -5,715 -2,691 2,099 517
Enterprise Value (EV)
0.00 8,164 93,920 119,447 145,014 182,653 168,627 213,594 222,092
Market Capitalization
0.00 3.51 79,428 107,657 132,410 172,482 157,140 199,700 206,053
Book Value per Share
$0.00 $240,720.00 $93.63 $91.36 $90.15 $85.91 $80.97 $81.92 $80.00
Tangible Book Value per Share
$0.00 $80,000.00 $15.42 $11.02 $5.59 $6.23 $3.62 $1.18 $1.73
Total Capital
0.00 15,522 72,392 65,591 65,736 59,648 59,301 60,468 61,111
Total Debt
0.00 9,000 15,296 13,956 16,154 14,207 17,914 19,373 21,623
Total Long-Term Debt
0.00 7,783 12,288 10,693 12,152 11,335 12,198 13,397 15,343
Net Debt
0.00 7,656 8,992 9,229 10,339 8,765 10,128 12,519 14,643
Capital Expenditures (CapEx)
1,465 1,311 1,883 3,682 3,400 3,086 3,173 3,787 4,497
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 578 2,858 -1,245 -2,568 -3,435 -3,152 -1,785 -169
Debt-free Net Working Capital (DFNWC)
0.00 1,195 7,324 1,455 1,186 -612 2,284 2,879 4,681
Net Working Capital (NWC)
0.00 -22 4,316 -1,808 -2,816 -3,484 -3,432 -3,097 -1,599
Net Nonoperating Expense (NNE)
104 40 -7.04 -219 -135 -211 -301 -139 -119
Net Nonoperating Obligations (NNO)
0.00 7,656 4,262 9,229 10,339 8,765 10,128 12,519 14,643
Total Depreciation and Amortization (D&A)
1,122 1,184 2,198 4,687 4,626 4,635 4,204 3,816 3,780
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.09% 19.26% -4.41% -9.43% -11.16% -9.45% -5.43% -0.51%
Debt-free Net Working Capital to Revenue
0.00% 10.52% 49.37% 5.15% 4.35% -1.99% 6.85% 8.76% 14.18%
Net Working Capital to Revenue
0.00% -0.19% 29.09% -6.41% -10.34% -11.31% -10.29% -9.43% -4.84%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $13.26 $4.22 $4.75 $7.40 $8.30 $12.70 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 330.40M 541.09M 526.74M 516.90M 499.74M 488.19M 478.77M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $13.11 $4.19 $4.71 $7.33 $8.23 $12.59 $13.62
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 334.13M 545.17M 531.16M 521.88M 504.04M 492.29M 482.09M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 544.91M 532.96M 522.84M 507.74M 492.16M 481.58M 472.91M
Normalized Net Operating Profit after Tax (NOPAT)
1,713 1,376 4,657 2,580 2,870 3,956 4,743 6,233 6,729
Normalized NOPAT Margin
16.26% 12.12% 31.39% 9.14% 10.53% 12.85% 14.22% 18.97% 20.39%
Pre Tax Income Margin
19.44% 20.14% 34.03% 10.37% 12.42% 16.56% 16.61% 24.31% 25.96%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
11.78 15.21 26.00 78.03 30.43 67.22 88.98 40.94 34.47
NOPAT to Interest Expense
8.64 8.37 21.77 56.91 21.66 48.71 63.17 31.01 25.85
EBIT Less CapEx to Interest Expense
4.07 7.06 16.67 -18.87 0.86 27.14 38.62 22.01 16.91
NOPAT Less CapEx to Interest Expense
0.93 0.23 12.45 -39.99 -7.91 8.63 12.81 12.07 8.28
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
55.66% 68.88% 26.47% 79.42% 77.23% 55.26% 54.75% 39.14% 39.41%
Augmented Payout Ratio
70.48% 69.80% 40.07% 191.05% 170.79% 171.70% 175.47% 101.56% 105.94%

Quarterly Metrics And Ratios for Linde

This table displays calculated financial ratios and metrics derived from Linde's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.81% -0.22% -2.99% -7.30% 5.10% -1.14% 0.77% 2.46% -0.24% 0.15% 2.76%
EBITDA Growth
7.14% 10.17% 73.13% 12.36% 11.66% 5.74% 5.80% 1.48% 7.06% 1.81% 5.14%
EBIT Growth
25.90% 28.11% 215.82% 25.27% 18.45% 8.44% 8.61% 2.11% 12.05% 4.43% 8.06%
NOPAT Growth
30.19% 33.85% 378.76% 27.11% 19.66% 8.23% 6.34% 1.19% 11.12% 2.66% 6.46%
Net Income Growth
28.88% 28.26% 293.17% 23.15% 15.80% 7.28% 5.46% 0.12% 12.25% 2.52% 6.24%
EPS Growth
33.17% 33.04% 331.08% 25.59% 18.87% 9.48% 7.84% 0.94% 14.60% 4.78% 8.43%
Operating Cash Flow Growth
-35.20% -4.60% 0.80% -4.40% 30.17% 2.41% -10.28% 8.37% 3.01% 10.59% 14.62%
Free Cash Flow Firm Growth
-40.51% -32.10% -105.88% -126.70% -113.45% -60.54% 259.64% 22.71% 326.73% -164.27% -575.80%
Invested Capital Growth
-4.96% -2.18% 3.66% 7.57% 4.07% 1.00% 1.92% 6.13% 0.96% 4.25% 8.29%
Revenue Q/Q Growth
-10.21% 3.72% 0.13% -0.60% 1.80% -2.43% 2.06% 1.08% -0.89% -2.05% 4.72%
EBITDA Q/Q Growth
-0.37% 8.33% 3.08% 0.99% -0.98% 2.59% 3.14% -3.13% 4.46% -2.45% 6.51%
EBIT Q/Q Growth
4.74% 13.35% 3.94% 1.51% -0.96% 3.77% 4.10% -4.57% 8.68% -3.28% 7.72%
NOPAT Q/Q Growth
6.08% 15.30% 4.43% -0.49% -0.14% 4.29% 2.60% -5.30% 9.66% -3.65% 6.40%
Net Income Q/Q Growth
4.69% 14.03% 3.87% -0.68% -1.56% 5.65% 2.10% -5.71% 10.36% -3.50% 5.80%
EPS Q/Q Growth
4.33% 15.47% 4.25% 0.00% -1.25% 6.35% 2.69% -6.40% 12.11% -2.77% 6.27%
Operating Cash Flow Q/Q Growth
-20.52% -8.93% 12.68% 17.21% 8.21% -28.35% -1.28% 41.58% 2.86% -23.07% 2.31%
Free Cash Flow Firm Q/Q Growth
-52.84% -31.54% -113.95% -492.93% 76.25% 300.92% -43.59% -387.09% 169.68% -156.96% -317.61%
Invested Capital Q/Q Growth
1.97% 7.06% 0.42% -1.87% -1.35% 3.89% 1.33% 2.19% -6.15% 7.27% 5.26%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.95% 45.92% 47.39% 47.10% 46.63% 47.95% 48.58% 47.87% 47.84% 48.75% 49.31%
EBITDA Margin
34.19% 35.71% 36.76% 37.35% 36.33% 38.20% 38.60% 36.99% 38.99% 38.83% 39.49%
Operating Margin
21.36% 23.59% 24.51% 25.16% 24.43% 25.86% 26.42% 24.96% 27.41% 26.92% 27.71%
EBIT Margin
22.09% 24.14% 25.06% 25.59% 24.90% 26.48% 27.01% 25.50% 27.96% 27.61% 28.40%
Profit (Net Income) Margin
17.23% 18.94% 19.65% 19.63% 18.98% 20.56% 20.56% 19.18% 21.36% 21.04% 21.26%
Tax Burden Percent
79.40% 79.96% 80.44% 78.21% 78.96% 80.05% 78.59% 77.70% 78.17% 78.30% 76.98%
Interest Burden Percent
98.22% 98.13% 97.47% 98.08% 96.57% 96.97% 96.87% 96.81% 97.71% 97.32% 97.22%
Effective Tax Rate
22.64% 22.15% 21.86% 23.79% 23.00% 22.26% 23.49% 24.14% 23.55% 23.44% 24.42%
Return on Invested Capital (ROIC)
10.43% 10.98% 11.65% 11.87% 11.76% 11.88% 11.87% 11.17% 12.84% 11.96% 11.84%
ROIC Less NNEP Spread (ROIC-NNEP)
11.02% 11.35% 11.96% 12.16% 11.88% 12.13% 12.05% 11.30% 13.08% 12.17% 11.99%
Return on Net Nonoperating Assets (RNNOA)
2.40% 3.42% 3.85% 3.94% 3.26% 4.36% 4.63% 4.36% 4.41% 5.20% 5.73%
Return on Equity (ROE)
12.83% 14.40% 15.51% 15.81% 15.02% 16.24% 16.50% 15.52% 17.25% 17.17% 17.57%
Cash Return on Invested Capital (CROIC)
12.62% 10.02% 6.72% 4.04% 7.81% 10.42% 9.59% 5.56% 11.32% 7.55% 3.56%
Operating Return on Assets (OROA)
9.14% 9.87% 10.59% 10.92% 10.19% 10.80% 11.16% 10.50% 11.47% 11.18% 11.36%
Return on Assets (ROA)
7.13% 7.75% 8.30% 8.37% 7.77% 8.38% 8.49% 7.90% 8.76% 8.52% 8.50%
Return on Common Equity (ROCE)
12.42% 13.93% 15.00% 15.28% 14.52% 15.69% 15.94% 14.99% 16.65% 16.56% 16.95%
Return on Equity Simple (ROE_SIMPLE)
0.00% 11.57% 14.60% 15.75% 0.00% 16.62% 17.14% 16.71% 0.00% 17.82% 0.00%
Net Operating Profit after Tax (NOPAT)
1,305 1,505 1,571 1,564 1,562 1,629 1,671 1,582 1,735 1,672 1,779
NOPAT Margin
16.52% 18.37% 19.15% 19.18% 18.81% 20.11% 20.21% 18.94% 20.95% 20.61% 20.94%
Net Nonoperating Expense Percent (NNEP)
-0.59% -0.37% -0.31% -0.29% -0.13% -0.25% -0.19% -0.13% -0.25% -0.21% -0.14%
Return On Investment Capital (ROIC_SIMPLE)
2.20% - - - 2.58% - - - 2.84% 2.64% 2.70%
Cost of Revenue to Revenue
56.05% 54.08% 52.61% 52.90% 53.37% 52.05% 51.42% 52.13% 52.16% 51.25% 50.69%
SG&A Expenses to Revenue
9.67% 10.03% 10.15% 9.91% 10.02% 10.62% 10.16% 9.85% 9.83% 9.69% 10.24%
R&D to Revenue
0.46% 0.44% 0.43% 0.44% 0.47% 0.47% 0.44% 0.44% 0.47% 0.47% 0.45%
Operating Expenses to Revenue
22.60% 22.32% 22.88% 21.94% 22.20% 22.09% 22.16% 22.91% 20.43% 21.83% 21.60%
Earnings before Interest and Taxes (EBIT)
1,745 1,978 2,056 2,087 2,067 2,145 2,233 2,131 2,316 2,240 2,413
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,701 2,926 3,016 3,046 3,016 3,094 3,191 3,091 3,229 3,150 3,355
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.93 4.32 4.64 4.65 5.03 5.89 5.66 5.99 5.41 6.03 6.00
Price to Tangible Book Value (P/TBV)
87.74 188.93 195.99 212.73 350.35 423.97 0.00 0.00 249.76 0.00 0.00
Price to Revenue (P/Rev)
4.71 5.18 5.60 5.58 6.08 6.98 6.58 7.11 6.24 6.94 6.95
Price to Earnings (P/E)
37.89 38.47 32.54 30.25 32.21 36.22 33.76 36.77 31.39 34.66 34.39
Dividend Yield
1.47% 1.36% 1.30% 1.36% 1.26% 1.12% 1.21% 1.14% 1.33% 1.22% 1.23%
Earnings Yield
2.64% 2.60% 3.07% 3.31% 3.10% 2.76% 2.96% 2.72% 3.19% 2.88% 2.91%
Enterprise Value to Invested Capital (EV/IC)
3.27 3.41 3.62 3.62 3.98 4.41 4.15 4.39 4.10 4.29 4.15
Enterprise Value to Revenue (EV/Rev)
5.05 5.63 6.06 6.05 6.50 7.49 7.14 7.67 6.73 7.55 7.63
Enterprise Value to EBITDA (EV/EBITDA)
17.19 18.64 17.68 16.81 17.79 20.16 18.97 20.43 17.62 19.68 19.77
Enterprise Value to EBIT (EV/EBIT)
30.08 31.10 26.96 24.98 26.09 29.37 27.45 29.52 25.17 27.94 27.86
Enterprise Value to NOPAT (EV/NOPAT)
42.37 43.10 35.77 33.05 34.44 38.79 36.46 39.29 33.56 37.41 37.45
Enterprise Value to Operating Cash Flow (EV/OCF)
19.02 21.42 22.83 22.66 22.95 26.24 25.65 27.11 23.57 25.88 25.58
Enterprise Value to Free Cash Flow (EV/FCFF)
25.28 33.61 54.86 92.72 52.06 42.48 43.67 81.34 36.41 58.02 121.19
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.43 0.45 0.42 0.45 0.47 0.51 0.54 0.55 0.55 0.61 0.65
Long-Term Debt to Equity
0.29 0.28 0.33 0.33 0.33 0.38 0.43 0.43 0.39 0.45 0.49
Financial Leverage
0.22 0.30 0.32 0.32 0.27 0.36 0.38 0.39 0.34 0.43 0.48
Leverage Ratio
1.86 1.90 1.90 1.92 1.95 1.97 1.97 1.98 2.00 2.05 2.09
Compound Leverage Factor
1.82 1.87 1.86 1.88 1.88 1.91 1.91 1.92 1.95 1.99 2.03
Debt to Total Capital
30.21% 31.24% 29.78% 30.91% 32.04% 33.56% 35.24% 35.41% 35.38% 37.72% 39.33%
Short-Term Debt to Total Capital
9.64% 11.70% 6.75% 8.19% 9.88% 8.41% 7.51% 7.61% 10.28% 9.93% 9.44%
Long-Term Debt to Total Capital
20.57% 19.54% 23.03% 22.72% 22.16% 25.15% 27.72% 27.80% 25.11% 27.79% 29.89%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.29% 2.27% 2.28% 2.30% 2.27% 2.31% 2.25% 2.27% 2.28% 2.26% 2.23%
Common Equity to Total Capital
67.50% 66.49% 67.95% 66.79% 65.69% 64.13% 62.52% 62.31% 62.33% 60.03% 58.44%
Debt to EBITDA
1.83 1.86 1.54 1.54 1.61 1.67 1.74 1.80 1.72 1.89 2.02
Net Debt to EBITDA
1.03 1.37 1.24 1.21 1.04 1.27 1.37 1.38 1.16 1.47 1.65
Long-Term Debt to EBITDA
1.24 1.17 1.19 1.13 1.12 1.25 1.37 1.41 1.22 1.39 1.54
Debt to NOPAT
4.50 4.31 3.12 3.03 3.12 3.21 3.35 3.45 3.27 3.59 3.83
Net Debt to NOPAT
2.54 3.17 2.52 2.37 2.02 2.45 2.63 2.65 2.21 2.79 3.12
Long-Term Debt to NOPAT
3.06 2.69 2.41 2.23 2.16 2.41 2.64 2.71 2.32 2.64 2.91
Altman Z-Score
3.26 3.19 3.55 3.50 3.62 4.06 3.86 4.03 3.74 3.88 3.71
Noncontrolling Interest Sharing Ratio
3.18% 3.26% 3.28% 3.35% 3.31% 3.39% 3.35% 3.43% 3.44% 3.55% 3.57%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.79 0.73 0.78 0.83 0.80 0.91 0.95 0.96 0.89 0.94 0.93
Quick Ratio
0.61 0.55 0.56 0.61 0.60 0.69 0.71 0.72 0.65 0.71 0.68
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,996 2,736 -382 -2,262 -537 1,080 609 -1,749 1,218 -694 -2,898
Operating Cash Flow to CapEx
223.82% 230.16% 250.29% 265.82% 236.92% 186.45% 170.26% 256.19% 224.72% 170.16% 175.90%
Free Cash Flow to Firm to Interest Expense
128.91 73.94 -7.34 -56.55 -7.57 16.61 8.70 -25.71 22.99 -11.57 -43.25
Operating Cash Flow to Interest Expense
67.58 51.57 41.35 63.00 38.41 30.06 27.56 40.16 53.00 36.02 33.00
Operating Cash Flow Less CapEx to Interest Expense
37.39 29.16 24.83 39.30 22.20 13.94 11.37 24.49 29.42 14.85 14.24
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.41 0.41 0.42 0.43 0.41 0.41 0.41 0.41 0.41 0.41 0.40
Accounts Receivable Turnover
7.37 6.95 6.89 6.99 7.08 6.71 6.70 6.91 7.07 6.63 6.50
Inventory Turnover
10.48 9.99 9.55 8.89 8.55 8.32 8.25 8.29 8.44 8.37 8.13
Fixed Asset Turnover
1.35 0.00 0.00 1.40 1.37 1.36 1.36 1.35 1.34 1.32 1.29
Accounts Payable Turnover
5.99 6.03 5.83 6.01 5.82 5.93 5.90 6.17 6.20 6.41 6.29
Days Sales Outstanding (DSO)
49.55 52.53 52.95 52.25 51.53 54.38 54.49 52.85 51.65 55.05 56.16
Days Inventory Outstanding (DIO)
34.82 36.53 38.21 41.04 42.70 43.88 44.25 44.05 43.23 43.63 44.89
Days Payable Outstanding (DPO)
60.97 60.52 62.65 60.70 62.76 61.54 61.88 59.18 58.84 56.95 58.05
Cash Conversion Cycle (CCC)
23.40 28.54 28.51 32.59 31.48 36.72 36.85 37.72 36.04 41.73 43.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
51,515 55,151 55,381 54,347 53,614 55,700 56,443 57,678 54,131 58,066 61,120
Invested Capital Turnover
0.63 0.60 0.61 0.62 0.63 0.59 0.59 0.59 0.61 0.58 0.57
Increase / (Decrease) in Invested Capital
-2,691 -1,231 1,953 3,826 2,099 549 1,062 3,331 517 2,366 4,677
Enterprise Value (EV)
168,627 187,864 200,685 196,486 213,594 245,391 234,229 253,197 222,092 249,204 253,517
Market Capitalization
157,140 172,683 185,215 181,037 199,700 228,520 215,965 234,692 206,053 229,170 230,912
Book Value per Share
$80.97 $81.21 $81.41 $79.72 $81.92 $80.57 $79.43 $82.04 $80.00 $80.42 $81.72
Tangible Book Value per Share
$3.62 $1.86 $1.93 $1.74 $1.18 $1.12 ($0.08) ($0.10) $1.73 ($0.08) ($2.93)
Total Capital
59,301 60,113 58,738 58,241 60,468 60,548 61,069 62,865 61,111 63,360 65,906
Total Debt
17,914 18,777 17,490 18,003 19,373 20,319 21,518 22,262 21,623 23,897 25,920
Total Long-Term Debt
12,198 11,744 13,528 13,232 13,397 15,227 16,931 17,475 15,343 17,608 19,701
Net Debt
10,128 13,815 14,133 14,109 12,519 15,471 16,892 17,075 14,643 18,603 21,134
Capital Expenditures (CapEx)
936 829 859 948 1,151 1,048 1,133 1,066 1,250 1,270 1,257
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3,152 -2,810 -2,536 -1,548 -1,785 -1,043 -700 -989 -169 107 346
Debt-free Net Working Capital (DFNWC)
2,284 2,152 821 2,346 2,879 3,805 3,926 4,198 4,681 5,401 5,132
Net Working Capital (NWC)
-3,432 -4,881 -3,141 -2,425 -3,097 -1,287 -661 -589 -1,599 -888 -1,087
Net Nonoperating Expense (NNE)
-56 -47 -41 -37 -14 -36 -29 -21 -34 -35 -27
Net Nonoperating Obligations (NNO)
10,128 13,815 14,133 14,109 12,519 15,471 16,892 17,075 14,643 18,603 21,134
Total Depreciation and Amortization (D&A)
956 948 960 959 949 949 958 960 913 910 942
Debt-free, Cash-free Net Working Capital to Revenue
-9.45% -8.43% -7.66% -4.77% -5.43% -3.18% -2.13% -2.99% -0.51% 0.32% 1.04%
Debt-free Net Working Capital to Revenue
6.85% 6.45% 2.48% 7.23% 8.76% 11.61% 11.96% 12.71% 14.18% 16.36% 15.44%
Net Working Capital to Revenue
-10.29% -14.64% -9.49% -7.47% -9.43% -3.93% -2.01% -1.78% -4.84% -2.69% -3.27%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $3.08 $3.22 $3.21 $0.00 $3.38 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
499.74M 491.82M 489.62M 487.12M 488.19M 481.95M 479.97M 477.66M 478.77M 473.30M 470.87M
Adjusted Diluted Earnings per Share
$2.65 $3.06 $3.19 $3.19 $3.15 $3.35 $3.44 $3.22 $3.61 $3.51 $3.73
Adjusted Weighted Average Diluted Shares Outstanding
504.04M 495.68M 493.55M 491.08M 492.29M 485.59M 483.18M 480.90M 482.09M 476.26M 473.57M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
492.16M 490.25M 487.95M 484.89M 481.58M 480.68M 477.50M 476.16M 472.91M 471.29M 468.91M
Normalized Net Operating Profit after Tax (NOPAT)
1,324 1,519 1,589 1,565 1,560 1,629 1,671 1,692 1,735 1,714 1,779
Normalized NOPAT Margin
16.77% 18.54% 19.36% 19.19% 18.79% 20.11% 20.21% 20.25% 20.95% 21.13% 20.94%
Pre Tax Income Margin
21.70% 23.69% 24.43% 25.10% 24.04% 25.68% 26.16% 24.69% 27.32% 26.87% 27.62%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
56.29 53.46 39.54 52.18 29.11 33.00 31.90 31.34 43.70 37.33 36.01
NOPAT to Interest Expense
42.10 40.67 30.22 39.10 21.99 25.06 23.87 23.27 32.74 27.87 26.55
EBIT Less CapEx to Interest Expense
26.10 31.05 23.02 28.48 12.90 16.88 15.71 15.66 20.11 16.17 17.25
NOPAT Less CapEx to Interest Expense
11.91 18.26 13.70 15.40 5.78 8.93 7.69 7.59 9.16 6.70 7.79
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
54.75% 51.37% 41.42% 40.03% 39.14% 39.17% 39.28% 39.91% 39.41% 39.74% 39.70%
Augmented Payout Ratio
175.47% 144.56% 103.33% 99.04% 101.56% 103.32% 110.70% 103.81% 105.94% 106.89% 101.03%

Key Financial Trends

Analysis of Linde PLC's financials over the past four years shows a solid growth and stable financial health with some fluctuations in cash flows and liabilities.

  • Consistent increase in Operating Revenue from approximately $7.9 billion in Q4 2022 to $8.5 billion in Q2 2025, indicating steady top-line growth.
  • Gross profit has improved consistently, growing from about $3.47 billion in Q4 2022 to around $4.19 billion by Q2 2025, reflecting effective cost management and pricing power.
  • Net income continued to rise, with Q2 2025 net income reaching approximately $1.81 billion compared to $1.36 billion in Q4 2022, pointing to improving profitability.
  • Strong operating cash flow, with net cash from continuing operating activities around $2.23 billion in Q2 2025, highlighting robust cash generation capacity.
  • Significant investment in property, plant, and equipment ($1.26 billion in Q2 2025), supporting long-term growth and capacity expansion.
  • Maintained dividend payments and share repurchases (e.g., around $704 million dividends and $1.11 billion in repurchases in Q2 2025), reflecting shareholder return commitment.
  • Long-term debt has increased from approximately $12.2 billion in end-2022 to around $19.7 billion in Q2 2025, which may indicate leverage used for growth or capital expenditures.
  • Goodwill and intangible assets have grown, reflecting acquisitions and investments in intangible resources, requiring monitoring for impairment risks.
  • Negative net cash flow from investing and financing activities in recent periods indicates substantial capital expenditures and debt repayments exceeding new financing in some quarters.
  • Accumulated other comprehensive loss remains significant (around -$6.25 billion in Q2 2025), which could reflect currency translation losses or other comprehensive income volatility.

Overall, Linde demonstrates strong revenue growth, profitability, and cash flow generation, underpinned by continuous investment in fixed assets and shareholder returns. The increase in debt and comprehensive losses warrant ongoing observation, but the company's financial standing remains solid based on recent quarters data.

08/14/25 06:00 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Linde's Financials

When does Linde's financial year end?

According to the most recent income statement we have on file, Linde's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Linde's net income changed over the last 8 years?

Linde's net income appears to be on an upward trend, with a most recent value of $6.74 billion in 2024, rising from $1.54 billion in 2016. The previous period was $6.34 billion in 2023. Find out what analysts predict for Linde in the coming months.

What is Linde's operating income?
Linde's total operating income in 2024 was $8.64 billion, based on the following breakdown:
  • Total Gross Profit: $15.86 billion
  • Total Operating Expenses: $7.23 billion
How has Linde's revenue changed over the last 8 years?

Over the last 8 years, Linde's total revenue changed from $10.53 billion in 2016 to $33.01 billion in 2024, a change of 213.3%.

How much debt does Linde have?

Linde's total liabilities were at $40.66 billion at the end of 2024, a 2.4% increase from 2023, and a 192.2% increase since 2017.

How much cash does Linde have?

In the past 7 years, Linde's cash and equivalents has ranged from $617 million in 2017 to $5.44 billion in 2022, and is currently $4.85 billion as of their latest financial filing in 2024.

How has Linde's book value per share changed over the last 8 years?

Over the last 8 years, Linde's book value per share changed from 0.00 in 2016 to 80.00 in 2024, a change of 7,999.9%.



This page (NASDAQ:LIN) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners